Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences

Area of Science:

• Genetics
• Public Health
• Pediatrics

Background:

• Newborn screening (NBS) programs are crucial for early detection of genetic and metabolic disorders.
• Expanding NBS panels to include conditions like Pompe disease, MPS I, ALD, and SMA requires assessing program readiness.
• Understanding implementation timelines and barriers is vital for efficient expansion of NBS.

Purpose of the Study:

• To evaluate the time and factors involved in implementing statewide newborn screening for four specific disorders.
• To assess the readiness of NBS programs across different phases of implementation.
• To identify facilitators and barriers encountered during the statewide rollout of new NBS tests.

Main Methods:

• Data collected from 39 newborn screening programs.
• Readiness assessed through four phases: approval, capabilities (lab, IT, follow-up), education, and implementation.
• Survival curve analysis used to estimate median time to statewide screening.

Main Results:

• 17 states (43.6%) implemented at least one new disorder statewide.
• Median implementation times varied: Pompe/MPS I (75 months), ALD (66 months), SMA (20 months).
• Laboratory readiness was a lengthy process (approx. 39 months); staffing/hiring challenges were the primary barrier.

Conclusions:

• Statewide implementation of new NBS disorders is a lengthy process, often exceeding several years.
• Laboratory capacity and adequate staffing are critical for successful NBS expansion.
• Inter-program collaboration and effective hiring strategies are key facilitators for overcoming implementation hurdles.